- Home
- BRFS vs ELAN Comparison
BRFS vs ELAN Comparison
Compare BRFS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRFS
- ELAN
- Stock Information
- Founded
- BRFS 1934
- ELAN 1954
- Country
- BRFS Brazil
- ELAN United States
- Employees
- BRFS N/A
- ELAN N/A
- Industry
- BRFS Meat/Poultry/Fish
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- BRFS Consumer Staples
- ELAN Health Care
- Exchange
- BRFS Nasdaq
- ELAN Nasdaq
- Market Cap
- BRFS 5.5B
- ELAN 6.0B
- IPO Year
- BRFS 2000
- ELAN 2018
- Fundamental
- Price
- BRFS $3.62
- ELAN $13.48
- Analyst Decision
- BRFS Hold
- ELAN Buy
- Analyst Count
- BRFS 2
- ELAN 6
- Target Price
- BRFS $13.75
- ELAN $15.17
- AVG Volume (30 Days)
- BRFS 4.3M
- ELAN 5.8M
- Earning Date
- BRFS 08-13-2025
- ELAN 08-07-2025
- Dividend Yield
- BRFS 2.74%
- ELAN N/A
- EPS Growth
- BRFS N/A
- ELAN N/A
- EPS
- BRFS 0.41
- ELAN 0.75
- Revenue
- BRFS $11,077,622,712.00
- ELAN $4,427,000,000.00
- Revenue This Year
- BRFS $11.01
- ELAN $4.28
- Revenue Next Year
- BRFS $4.38
- ELAN $4.67
- P/E Ratio
- BRFS $9.12
- ELAN $17.93
- Revenue Growth
- BRFS 18.02
- ELAN 1.42
- 52 Week Low
- BRFS $2.99
- ELAN $8.02
- 52 Week High
- BRFS $4.87
- ELAN $18.55
- Technical
- Relative Strength Index (RSI)
- BRFS 48.08
- ELAN 56.01
- Support Level
- BRFS $3.53
- ELAN $13.32
- Resistance Level
- BRFS $3.86
- ELAN $14.15
- Average True Range (ATR)
- BRFS 0.12
- ELAN 0.38
- MACD
- BRFS -0.00
- ELAN -0.16
- Stochastic Oscillator
- BRFS 35.53
- ELAN 27.11
About BRFS BRF S.A.
BRF SA is an international producer of fresh and frozen protein foods. It operates by raising, producing, and slaughtering poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, pet food, and others. The Company holds as its main brands Sadia, Perdigao, Qualy, Chester, Kidelli, Perdix, Banvit, Biofresh, and Gran Plus, present mainly in Brazil, Turkey, and Middle Eastern countries. The group has three reportable segments, being; Brazil, International, and Other segments.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.